Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.1711
+0.0001 (0.06%)
At close: Mar 12, 2026, 4:00 PM EDT
0.1740
+0.0029 (1.69%)
After-hours: Mar 12, 2026, 7:59 PM EDT
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $9.04 million as of March 12, 2026. Its market cap has decreased by -81.33% in one year.
Market Cap
9.04M
Enterprise Value
31.77M
1-Year Change
-81.33%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $9.04M, a decrease of -94.96%. That is a compound annual growth rate of -31.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 9.04M | -48.93% |
| Dec 31, 2025 | 17.70M | -63.66% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 10.01M |
| SeaStar Medical Holding | 9.99M |
| BiomX | 9.94M |
| CollPlant Biotechnologies | 8.80M |
| TransCode Therapeutics | 8.78M |
| Cardio Diagnostics Holdings | 8.69M |
| Alzamend Neuro | 8.29M |
| Theriva Biologics | 8.20M |